Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tezacaftor/Ivacaftor Chest Imaging Study in CF
NCT02730208Phase 2Completed
- Sponsor
- Vertex Pharmaceuticals
- Start
- Sep 2016
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tezacaftor in cystic fibrosis (CF), sponsored by Vertex Pharmaceuticals. Started Sep 2016; status: completed.
02
Drugs
tezacaftor
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT02730208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02730208.